Enhabit, Inc. (EHAB)
Trading
Quantity
Profitability
Ownership
Largest Insider Buys in Sector
EHAB Insider Trading Activity
EHAB Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $526,487 | 10 | 91 |
Sells | $9,404 | 1 | 9 |
Related Transactions
| Bolton Jeffrey | director | 8 | $376,337 | 0 | $0 | $376,337 |
| MCGUIGAN STUART M | director | 1 | $132,150 | 0 | $0 | $132,150 |
| Hoeflinger Erin | director | 1 | $18,000 | 0 | $0 | $18,000 |
| McQuiddy Collin | Chief Accounting Officer | 0 | $0 | 1 | $9,404 | $-9,404 |
About Enhabit, Inc.
Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific …
Insider Activity of Enhabit, Inc.
Over the last 12 months, insiders at Enhabit, Inc. have bought $526,487 and sold $9,404 worth of Enhabit, Inc. stock.
On average, over the past 5 years, insiders at Enhabit, Inc. have bought $672,474 and sold $7,495 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Bolton Jeffrey (director) — $376,337. MCGUIGAN STUART M (director) — $132,150. Hoeflinger Erin (director) — $18,000.
The last purchase of 4,000 shares for transaction amount of $34,760 was made by Bolton Jeffrey (director) on 2024‑12‑12.
List of Insider Buy and Sell Transactions, Enhabit, Inc.
| 2025-03-10 | Sale | McQuiddy Collin | Chief Accounting Officer | 1,096 0.0022% | $8.58 | $9,404 | +1.50% | |
| 2024-12-12 | Bolton Jeffrey | director | 4,000 0.0081% | $8.69 | $34,760 | -1.41% | ||
| 2024-12-10 | MCGUIGAN STUART M | director | 15,000 0.0306% | $8.81 | $132,150 | -2.04% | ||
| 2024-11-12 | Bolton Jeffrey | director | 3,000 0.006% | $7.60 | $22,800 | +8.94% | ||
| 2024-11-08 | Bolton Jeffrey | director | 7,000 0.0139% | $7.77 | $54,377 | +4.82% | ||
| 2024-08-22 | Bolton Jeffrey | director | 5,000 0.0099% | $8.01 | $40,050 | -0.37% | ||
| 2024-08-09 | Bolton Jeffrey | director | 5,000 0.0098% | $8.29 | $41,450 | -5.32% | ||
| 2024-08-08 | Bolton Jeffrey | director | 2,000 0.004% | $8.60 | $17,200 | -5.99% | ||
| 2024-05-17 | Bolton Jeffrey | director | 10,000 0.0193% | $8.33 | $83,300 | +0.85% | ||
| 2024-05-14 | Hoeflinger Erin | director | 2,000 0.004% | $9.00 | $18,000 | -7.85% | ||
| 2024-05-10 | Bolton Jeffrey | director | 10,000 0.0197% | $8.24 | $82,400 | +0.12% | ||
| 2024-03-01 | Sale | Langham Ronald Leroy JR | EVP Clinical Excel. & Strategy | 634 0.0013% | $8.81 | $5,586 | -4.20% | |
| 2023-05-26 | Bolton Jeffrey | director | 2,000 0.004% | $11.61 | $23,220 | -7.53% | ||
| 2023-05-22 | SHAW L EDWARD JR | director | 10,000 0.0198% | $11.98 | $119,800 | -12.00% | ||
| 2023-05-18 | Langham Ronald Leroy JR | EVP Clinical Excel. & Strategy | 10,000 0.02% | $11.99 | $119,900 | -10.49% | ||
| 2023-05-18 | Hoeflinger Erin | director | 2,100 0.0042% | $11.82 | $24,822 | -10.49% | ||
| 2023-05-17 | Bolton Jeffrey | director | 2,000 0.0039% | $11.80 | $23,600 | -10.64% | ||
| 2022-11-18 | Bolton Jeffrey | director | 1,000 0.002% | $12.69 | $12,690 | -0.82% | ||
| 2022-11-09 | Bolton Jeffrey | director | 2,000 0.004% | $12.75 | $25,500 | +0.08% | ||
| 2022-11-08 | Bolton Jeffrey | director | 2,000 0.004% | $12.89 | $25,780 | -1.77% |
Insider Historical Profitability
| Bolton Jeffrey | director | 98144 0.1944% | $863,667.20 | 14 | 0 | <0.0001% |
| MCGUIGAN STUART M | director | 46810 0.0927% | $411,928.00 | 1 | 0 | |
| Hoeflinger Erin | director | 30399 0.0602% | $267,511.20 | 3 | 0 | <0.0001% |
| Jacobsmeyer Barbara Ann | President and CEO | 238442 0.4723% | $2.1M | 1 | 0 | +3.36% |
| Langham Ronald Leroy JR | EVP Clinical Excel. & Strategy | 57164 0.1132% | $503,043.20 | 1 | 1 | <0.0001% |
EHAB Institutional Investors: Active Positions
| Increased Positions | 76 | +34.39% | 6M | +11.76% |
| Decreased Positions | 92 | -41.63% | 4M | -9.2% |
| New Positions | 23 | New | 731,989 | New |
| Sold Out Positions | 38 | Sold Out | 1M | Sold Out |
| Total Postitions | 205 | -7.24% | 49M | +2.57% |
EHAB Ownership Change vs Market
Institutional Investor Ownership
| Deerfield Management Company, L.P. (Series C) | $43,295.00 | 10.02% | 5.01M | +13,226 | +0.27% | 2024-12-31 |
| 8 Knots Management, Llc | $38,283.00 | 8.86% | 4.43M | +623,602 | +16.38% | 2024-12-31 |
| Blackrock, Inc. | $32,254.00 | 7.47% | 3.73M | -202,098 | -5.14% | 2024-12-31 |
| Ubs Group Ag | $25,178.00 | 5.83% | 2.91M | +1M | +73.08% | 2024-12-31 |
| Vanguard Group Inc | $25,166.00 | 5.83% | 2.91M | -63,777 | -2.14% | 2024-12-31 |
| Arex Capital Management, Lp | $21,520.00 | 4.98% | 2.49M | +48,874 | +2% | 2024-12-31 |
| Jana Partners Management, Lp | $18,465.00 | 4.27% | 2.14M | 0 | 0% | 2024-12-31 |
| Kent Lake Pr Llc | $17,280.00 | 4% | 2M | +750,000 | +60% | 2024-12-31 |
| Systematic Financial Management Lp | $17,246.00 | 3.99% | 2M | +157,914 | +8.59% | 2024-12-31 |
| Dimensional Fund Advisors Lp | $16,882.00 | 3.91% | 1.95M | +213,774 | +12.29% | 2024-12-31 |